¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"accelerated hypertension"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® hypertension ÇÑ±Û °íÇ÷¾Ð
¼³¸í   
  µ¿¸ÆÀÇ Ç÷¾ÐÀÌ ³ôÀº °Í. ÀϹÝÀûÀ¸·Î ¸»Çϴ °íÇ÷¾ÐÀº ÀÌ µ¿¸Æ¼º °íÇ÷¾ÐÀ» ¸»ÇÑ´Ù. Ç÷¾ÐÀ̶õ Ç÷°ü¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»Çϴ °ÍÀ¸·Î ´ë°³ Æ¯ÀÌÇÑ ¼³¸íÀÌ ¾øÀ¸¸é µ¿¸ÆÀÇ ¾Ð·ÂÀ» ¸»ÇÑ´Ù. Ç÷¾Ð¿¡´Â ¼öÃà±âÇ÷¾Ð°ú À̿ϱâÇ÷¾ÐÀÌ ÀÖ´Ù. ¼öÃà±âÇ÷¾ÐÀ̶õ ½ÉÀåÀÌ ¼öÃàÇÒ ¶§ÀÇ µ¿¸Æ¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»Çϰí À̿ϱâ Ç÷¾ÐÀ̶õ ½ÉÀåÀÌ ÀÌ¿ÏÇÒ °æ¿ì¿¡ µ¿¸Æ¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»ÇÑ´Ù. ´ç¿¬È÷ ¼öÃà±â Ç÷¾ÐÀÌ À̿ϱâ Ç÷¾Ðº¸´Ù ³ô´Ù. Ç÷¾ÐÀ» ¸»ÇÒ ¶§¿¡ 120/80À̶ó°í Àû´Â °ÍÀÇ ¾ÕÀÇ °ÍÀº ¼öÃà±â Ç÷¾ÐÀ» ÀǹÌÇÏ°í µÚ¿¡ Àû´Â 80Àº À̿ϱâ Ç÷¾ÐÀ» ÀǹÌÇÑ´Ù.
  
  °íÇ÷¾ÐÀº ÁַΠÀ̿ϱâÀÇ Ç÷¾ÐÀ» ±âÁØÀ¸·Î Á¤ÇÑ´Ù. ¿©·¯ °¡Áö ±âÁØÀÌ ÀÖÀ¸³ª À̿ϱâ Ç÷¾ÐÀÌ 90mmHgÀÌ»óÀΠ°æ¿ì¸¦ ¸»ÇÑ´Ù. °íÇ÷¾Ð ÀÚü¿¡ ÀÇÇÑ Áõ»óÀº º°·Î ¾ø´Ù. ´Ù¸¸ °íÇ÷¾Ð¿¡ ÀÇÇÑ ÇÕº´Áõ°ú µ¿¸Æ°æÈ­ÀÇ ÃËÁø¿¡ ÀÇÇØ º´¹ßÇϴ Áúȯ¿¡ ÀÇÇÏ¿© Áõ»óÀÌ »ý±ä´Ù. °íÇ÷¾Ð¿¡ ÀÇÇÑ ÇÕº´ÁõÀº ´ë°³ Ç÷°ü¿¡ °É¸®´Â °úµµÇÑ ¾Ð·ÂÀ¸·Î ÀÎÇÑ Ç÷°üÀÇ ¼Õ»óÀÌ Áß¿äÇÑ ¿øÀÎÀÌ´Ù.
  
  °íÇ÷¾ÐÀº µ¿¸Æ°æÈ­ÀÇ ÁÖ¿ä À¯¹ßÀÎÀÚ ÁßÀÇ ÇϳªÀÌ´Ù. µ¿¸Æ°æÈ­´Â µ¿¸ÆÀÇ º®ÀÌ µÎÅÍ¿öÁö°í µ¿¸ÆÀ̠ź·ÂÀ» ÀÒ¾î¹ö¸®´Â ÁúȯÀÌ´Ù. ¾î¶² µ¿¸ÆÀÌ µ¿¸Æ°æÈ­¿¡ °É¸®¸é ÀÌ µ¿¸ÆÀº µÎÅÍ¿öÁø Ç÷°üº®¿¡ ÀÇÇØ¼­ ³»°æÀÌ ÀÛ¾ÆÁö°Ô µÈ´Ù. ÀÌ·¸°Ô µÇ¸é ±× µ¿¸ÆÀ¸·ÎºÎÅÍ Ç÷¾×À» °ø±Þ¹Þ´ø Àå±â´Â Ç÷¾×À» Àû°Ô °ø±Þ¹Þ°Ô µÇ°í ±× Á¤µµ°¡ ½ÉÇϰԠµÇ¸é ±× Àå±â´Â °á±¹ ¼Õ»óÀ» ÀÔ°Ô µÈ´Ù. µ¿¸Æ°æÈ­·Î ÀÎÇÑ Áúº´ÀÇ ´ëÇ¥ÀûÀΠ¿¹´Â ½ÉÀåÀÇ ±ÙÀ°¿¡ Ç÷¾×À» °ø±ÞÇϴ ½ÉÀ嵿¸Æ¿¡ µ¿¸Æ°æÈ­ÀÇ º¯È­°¡ ¿À´Â ½ÉÀ嵿¸Æº´ÀÌ´Ù.
  
  °íÇ÷¾ÐÀÇ Ä¡·á¿¡ ¾²À̴ ¾à¹°Àº ´ÙÀ½°ú °°Àº °ÍÀÌ ÀÖ´Ù.
  
  -ÀÌ´¢Á¦-ÄáÆÏ¿¡¼­ ¼öºÐ°ú ÀüÇØÁúÀÇ ¹èÃâÀ» ÃËÁø½Ã۴ ¾à¹°. Ã¼³»ÀÇ ¼öºÐÀÇ ¾çÀ» °¨¼Ò½ÃÄѼ­ Ç÷¾×ÀÇ È帣´Â ¾çÀ» Àû°ÔÇÏ°í ¶Ç Ç÷°üÁÖÀ§ Á¶Á÷ÀÇ ¼öºÐÀÇ °¨¼Ò·Î Ç÷°üÀ» È®Àå½Ã۴ ¿ªÇÒ(Ç÷°üÀÌ ÀÖ°í ±× Ç÷°üÀ» ½×°í Àִ Á¶Á÷¿¡ ¼öºÐÀÌ Â÷ ÀÖÀ¸¸é ±× Á¶Á÷ÀÌ Ç÷°üÀ» ´­·¯¼­ Ç÷°üÀÌ È®ÀåÇϴ °ÍÀ» ¹æÇØÇÑ´Ù)·Î Ç÷¾ÐÀ» °¨¼Ò½ÃŲ´Ù.
  
  -Ä®½·-Åë·ÎÂ÷´ÜÁ¦£­¸ðµç ±ÙÀ°ÀÇ ¼öÃà¿¡´Â Ä®½·ÀÌ ÇÊ¿äÇÏ´Ù. Áï Ç÷°üÀÇ ¼öÃà¿¡ °ü¿©Çϴ Ç÷°üµµ ¿ª½Ã ¼öÃàÀ» À§Çؼ­´Â Ä®½·ÀÌ ÇÊ¿äÇÏ´Ù. Ä®½·-Åë·ÎÂ÷´ÜÁ¦´Â ±ÙÀ°¼¼Æ÷ ¼ÓÀ¸·Î Ä®½·ÀÌ µé¾î°¡´Â °ÍÀ» ¹æÁöÇØ¼­ Ç÷°ü±ÙÀ°ÀÇ ¼öÃàÀ» ¹æÇØÇϰí À̷ΠÀÎÇØ¼­ Ç÷°üÀÇ È®ÀåÀ» À¯µµÇÑ´Ù.
  
  -¾ËÆÄÂ÷´ÜÁ¦, º£Å¸Â÷´ÜÁ¦-Ç÷°üÀº ÀÚÀ²½Å°æ°èÀÇ Áö¹è¸¦ ¹Þ´Â´Ù. ±×Áß¿¡¼­µµ Ç÷°üÀº ±³°¨½Å°æÀÇ ¿µÇâ¿¡ ÀÇÇØ¼­ ¼öÃà°ú ÀÌ¿ÏÀ» ÇÑ´Ù. ±³°¨½Å°æÀÇ ÀÛ¿ëÀº ±× ¼ö¿ëü¿¡ µû¶ó ´Þ¶óÁø´Ù. ±³°¨½Å°æÀÇ ¼ö¿ëüÀÇ Á¾·ù¿¡´Â ¾ËÆÄ¼ö¿ëü¿Í º£Å¸¼ö¿ëü°¡ ÀÖ´Ù. Ç÷°üÀ» Áö¹èÇϰí Àִ ±³°¨½Å°æ¿¡¼­ ¾ËÆÄ¼ö¿ëü´Â Ç÷°üÀÇ ¼öÃàÀ» ÀÏÀ¸Å°°í º£Å¸¼ö¿ëü´Â Ç÷°üÀÇ È®ÀåÀ» ÀÏÀ¸Å²´Ù. ±×·¯¹Ç·Î ¾ËÆÄ¼ö¿ëüÀÇ ÀÛ¿ëÀ» ¸·´Â °æ¿ì¿¡ Ç÷°üÀÇ È®ÀåÀ» À¯µµÇÒ ¼ö ÀÖ°í º£Å¸-¼ö¿ëüÀÇ ÀÛ¿ëÀ» Ç×Áø½Ãų °æ¿ì¿¡ ¿ª½Ã Ç÷°üÀÇ È®Á¤À» À¯µµÇÒ ¼ö ÀÖ´Ù.
¿µ¹® renal hypertension ÇÑ±Û ÄáÆÏ¼º°íÇ÷¾Ð
¼³¸í   
  ÄáÆÏ½ÇÁúÀÇ º´º¯À¸·Î ÀÎÇØ ¾ß±âµÈ °íÇ÷¾Ð. ÄáÆÏÀÇ ´ëÇ¥Àû ±â´ÉÀº ³ëÆó¹° ¹× ¼öºÐÀÇ ¹è¼³ÀÌ´Ù. ±×·±µ¥ ÀÌ·¯ÇÑ ÄáÆÏ±â´É¿¡ ÀÌ»óÀÌ »ý°åÀ» °æ¿ì Ã¼³»¿¡ °úÀ×¼öºÐÀÇ ÃàÀûÀÌ ¹ß»ýÇϰԠµÈ´Ù. À̿Ͱ°Àº °úÀ×¼öºÐÀÇ ÃàÀûÀº Ç÷°ü³» Á¤¼ö¾ÐÀ» »ó½Â½ÃÄÑ °íÇ÷¾ÐÀ» À¯¹ßÇϰԠµÈ´Ù. Ä¡·á´Â ¿øÀΠÄáÆÏº´ÀÇ ±³Á¤À̸ç ÀÌÀ¯¸¦ ¸ð¸£´Â ¿ø¹ß°íÇ÷¾Ð°ú ´Þ¸® ÄáÆÏ¼º°íÇ÷¾ÐÀÇ °æ¿ì¿¡´Â ¿øÀΠÄáÆÏº´ÀÌ ±³Á¤µÇ¸é °íÇ÷¾Ðµµ »ç¶óÁö°Ô µÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated hypertension
    °¡¼Ó°íÇ÷¾Ð
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated hyperfractionation
    °¡¼Ó°úºÐÇÒ
  • accelerated idioventricular rhythm
    °¡¼Ó½É½Ç°íÀ¯¸®µë, °¡¼Ó½É½Ç°íÀ¯À²µ¿
  • accelerated repopulation
    °¡¼ÓÀçÁõ½Ä
  • continuous hyperfractionated accelerated radiotherapy
    ¿¬¼Ó°úºÐÇÒ°¡¼Ó¹æ»ç¼±Ä¡·á
  • adrenal hypertension
    ºÎ½Å¼º°íÇ÷¾Ð
  • borderline hypertension
    °æ°è°íÇ÷¾Ð
  • diastolic hypertension
    È®Àå±â°íÇ÷¾Ð
  • essential hypertension
    º»Å°íÇ÷¾Ð
  • hypertension
    1. °íÇ÷¾Ð 2. °íÇ÷¾ÐÁõ 3. °í¾Ð
  • intracranial hypertension
    µÎ°³³»¾Ð»ó½Â
  • juvenile hypertension
    ¼Ò¾Æ°íÇ÷¾Ð
  • labile hypertension
    ºÒ¾ÈÁ¤°íÇ÷¾Ð
  • low renin hypertension
    Àú·¹´Ñ°íÇ÷¾Ð
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾Ð
  • ocular hypertension
    °í¾È¾Ð
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypertension
    °íÇ÷¾Ð
  • ocular hypertension
    °í¾È¾ÐÁõ
  • portal hypertension
    ¹®¸Æ°íÇ÷¾Ð
  • pregnancy-induced hypertension
    ÀӽŰíÇ÷¾Ð
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, ÇãÆÄ°íÇ÷¾Ð
  • renovascular hypertension
    ÄáÆÏÇ÷°ü°íÇ÷¾Ð, ½ÅÀåÇ÷°ü°íÇ÷¾Ð
  • sinusoidal hypertension
    ±¼Ç÷°ü°íÇ÷¾Ð
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated hypertension
    °¡¼Ó°íÇ÷¾Ð
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated hyperfractionation
    °¡¼Ó°ú´ÙºÐÇÒÁ¶»ç
  • accelerated repopulation
    °¡¼ÓÀçÁõ½Ä
  • accelerated treatment
    °¡¼ÓÄ¡·á
  • accelerated idioventricular rhythm
    °¡¼Ó½É½Ç°íÀ¯¸®µë
  • continuous hyperfractionated accelerated radiotherapy
    ¿¬¼Ó°úºÐÇÒ°¡¼Ó¹æ»ç¼±Ä¡·á
  • adrenal hypertension
    ºÎ½Å°íÇ÷¾Ð
  • borderline hypertension
    °æ°è°íÇ÷¾Ð
  • diastolic hypertension
    È®Àå±â°íÇ÷¾Ð
  • essential hypertension
    º»Å°íÇ÷¾Ð
  • hypertension
    °íÇ÷¾Ð
  • intracranial hypertension
    µÎ°³³»¾Ð»ó½Â
  • juvenile hypertension
    ¼Ò¾Æ°íÇ÷¾Ð
  • labile hypertension
    (¢¡borderline hypertension) °æ°è°íÇ÷¾Ð
  • low renin hypertension
    Àú·¹´Ñ°íÇ÷¾Ð
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾Ð
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated hypertension
    °¡¼Ó¼º °íÇ÷¾Ð.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • accelerated fractionation
    °¡¼ÓºÐÇÒÁ¶»ç
  • accelerated hyperfractionation
    °¡¼Ó°úºÐÇÒÁ¶»ç
  • accelerated idioventricular rhythm
    °¡¼Ó½É½Ç°íÀ¯À²µ¿.
  • accelerated repopulation
    °¡¼ÓÀçÁõ½Ä
  • accelerated treatment
    °¡¼ÓÄ¡·á
  • Goldblatt hypertension
    Goldblatt °íÇ÷¾Ð(ÍÔúìäâ)
  • Hypertension
    °íÇ÷¾Ð(ÍÔúìäâ)
  • adrenal hypertension
    ºÎ½Å¼º °íÇ÷¾ÐÁõ(¡­ÍÔúìäâñø).
  • arterial hypertension
    µ¿¸Æ(¼º) °íÇ÷¾Ð(Áõ).
  • hypertension
    °íÇ÷¾Ð(Áõ)(ÍÔúìäâñø), ±äÀåÇ×Áø(Áõ)(ÑÌíåùñòäñø).
  • hypertension
    °íÇ÷¾Ð(Áõ)(ÍÔúìäâ)
  • hypertension cranienne ºÒ
    ³ú¾ÐÇ×Áø(Áõ).
  • hypertension paroxystique ºÒ
    ¹ßÀÛ¼º °íÇ÷¾Ð(Áõ)(Û¡íÂàõÍÔúìäâñø).
  • hypertension,benign nephrosclerosis
    ¾ç¼º ½Å°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated hypertension
    °¡¼Ó¼º °íÇ÷¾Ð.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • accelerated fractionation
    °¡¼ÓºÐÇÒÁ¶»ç
  • accelerated hyperfractionation
    °¡¼Ó°úºÐÇÒÁ¶»ç
  • accelerated idioventricular rhythm
    °¡¼Ó½É½Ç°íÀ¯À²µ¿.
  • accelerated repopulation
    °¡¼ÓÀçÁõ½Ä
  • accelerated treatment
    °¡¼ÓÄ¡·á
  • continuous hyperfractionated accelerated radiother
    apy (CHART) ¿¬¼Ó°úºÐÇÒ°¡¼Ó¹æ»ç¼±Ä¡·á
  • adrenal hypertension
    ºÎ½Å¼º °íÇ÷¾ÐÁõ(¡­ÍÔúìäâñø).
  • arterial hypertension
    µ¿¸Æ(¼º) °íÇ÷¾Ð(Áõ).
  • borderline hypertension
    °æ°è¿ª°íÇ÷¾Ð.
  • borderline hypertension
    °æ°è¿ª °íÇ÷¾Ð(ÌÑÍ£æ´ ÍÔúìäâ).
  • diastolic hypertension
    È®Àå±â°íÇ÷¾Ð(¡­ÍÔúìäâ).
  • essential hypertension
    º»Å¼º °íÇ÷¾Ð.
  • essential hypertension
    º»Å¼º(Üâ÷¾àõ)°íÇ÷¾Ð(ÍÔúìäâ)
  • hypertension
    °íÇ÷¾Ð(Áõ)(ÍÔúìäâñø), ±äÀåÇ×Áø(Áõ)(ÑÌíåùñòäñø).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • renal hypertension
    ½Å°íÇ÷¾Ð(ãìÍÔúìäâ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • essential hypertension
    º»Å¼º°íÇ÷¾Ð
  • hypertension
    °íÇ÷¾ÐÁõ, ±äÀåÇ×ÁøÁõ
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾ÐÁõ
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ, ¹®¸Æ°íÇ÷¾Ð
  • primary hypertension
    ¿ø¹ß(¼º)°íÇ÷¾ÐÁõ
  • renal hypertension
    ½Å¼º°íÇ÷¾Ð
  • renovascular hypertension
    ½ÅÇ÷°ü¼º°íÇ÷¾Ð
  • splenoportal hypertension
    ºñ¹®¸Æ¼º°íÇ÷¾ÐÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
IPH idiopathic portal hypertension; idiopathic pulmonary hemosiderosis; idiopathic pulmonary hypertensio...
PHT phenytoin; portal hypertension; primary hyperthyroidism; pulmonary hypertension
PPH past pertinent history; persistent pulmonary hypertension; phosphopyruvate hydratase; postpartum hem...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
STOP Hypertension Swedish Trial in Old Patients with Hypertension
AIVR Accelerated Idioventricular rhythm
AF Accelerated fractionation
ASE Accelerated solvent extraction
CHART Continuous Hyperfractionated Accelerated Radiotherapy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • accelerated hypertension
    °¡¼Ó¼º °íÇ÷¾Ð
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • accelerated death phase
    °¡¼Ó »ç¸ê±â
  • accelerated reaction
    ÃËÁø ¹ÝÀÀ, °¡¼Ó ¹ÝÀÀ
    º¸Åë ¶§º¸´Ù ´Ü ½Ã°£ ³»¿¡ ÀϾ´Â ¹ÝÀÀ.
  • essential hypertension
    º»Å¼º °íÇ÷¾Ð
    1. Ưº°ÇÑ ¿øÀÎÀÌ ¾Ë·ÁÁöÁö ¾ÊÀº °íÇ÷¾ÐÀ» ÀǹÌÇϸç ÀÌ´Â Àüü °íÇ÷¾Ð ȯÀÚÀÇ 85-90£¥¸¦ Â÷ÁöÇÑ´Ù. 2. À¯Àü, Á¤½ÅÀû ½ºÆ®·¹½º, ¿°ºÐÀÇ Áõ°¡ µî Ç÷¾Ð »ó½ÂÀÌ º¹ÇÕÀûÀÎ ¿øÀÎ ÇüÅ·Π³ªÅ¸³­´Ù.
  • hypertension paroxystique
    ºÒ ¹ßÀÛ¼º °íÇ÷¾Ð
  • juvenile hypertension
    ¿¬¼Ò¼º °íÇ÷¾ÐÁõ, ¿¬¼Ò¼º °íÇ÷¾Ð
  • labile hypertension
    ºÒ¾ÈÁ¤¼º °íÇ÷¾Ð
  • nephrogenous hypertension
    ½Å¼º °íÇ÷¾Ð
  • ocular hypertension indicator
    ¾È±¸ °íÇ÷¾Ð ÁöÇ¥
  • orthostatic hypertension
    ±â¸³¼º °íÇ÷¾Ð, ÀÚ¼¼¼º °íÇ÷¾Ð
  • portal hypertension
    ¹®¸Æ¼º °íÇ÷¾Ð, °£¹®¸Æ °íÇ÷¾Ð, ¹®¸Æ¾Ð Ç×ÁøÁõ, ¹®¸Æ °íÇ÷¾Ð
  • primary hypertension
    ¿ø¹ß °íÇ÷¾ÐÁõ, ¿ø¹ß¼º °íÇ÷¾ÐÁõ
  • pulmonary arterial hypertension
    Æó ¼øÈ¯ ½Â¾Ð
  • pulmonary hypertension
    Æó ¼øÈ¯ ½Â¾Ð, Æó °íÇ÷¾ÐÁõ
  • renal hypertension
    ½Å¼º °íÇ÷¾Ð
  • splenoportal hypertension
    ºñ ¹®¸Æ¼º °íÇ÷¾ÐÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
accelerated hypertension <cardiology> A severe form of acute hypertension that results in the abrupt rise in the blood pressure (diastolic pressure often over 120 mmHg). If left untreated, malignant hypertension can cause damage to the blood vessels in the eye, kidneys, brain and heart. Complications include stroke, heart attack, blindness and renal failure.
Symptoms include headache, blurred vision, nausea, vomiting and lethargy. Neurologic symptoms are also a common finding. Malignant hypertension occurs more commonly in males, African Americans and those with a history for hypertension.
(27 Sep 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
accelerated conduction Any pathologically increased speed of conduction; usually occurs between the atrium and ventricles as in the Wolff-Parkinson-White and Lown-Ganong-Levine syndromes; such accelerated pathways provide the bases for particular forms of reentry tachycardia.
(05 Mar 2000)
accelerated idioventricular rhythm A transient and intermittent type of arrhythmia with episodes lasting from a few seconds to a minute which usually occurs in patients with acute myocardial infarction or with digitalis toxicity. Suppressive therapy is rarely necessary because the ventricular rate is generally less than 100 beats per minute.
(12 Dec 1998)
accelerated phase of leukaemia Refers to chronic myelogenous leukaemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase, but not as high as in the blast phase.
(12 Dec 1998)
accelerated reaction A response occurring in a shorter time than expected; the cutaneous manifestations occurring during the period between the second and tenth day following smallpox vaccination; because it is intermediate between a primary reaction and an immediate reaction, it is regarded as evidence of some degree of resistance.
Synonym: vaccinoid reaction.
(05 Mar 2000)
accelerated rejection A transplant rejection manifested in less than three days.
(05 Mar 2000)
leukaemia, accelerated phase of Refers to chronic myelogenous leukaemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase, but not as high as in the blast phase.
(12 Dec 1998)
adrenal hypertension Hypertension due to an adrenal medullary pheochromocytoma or to hyperactivity or functioning tumour of the adrenal cortex.
(05 Mar 2000)
benign hypertension Hypertension that runs a relatively long and symptomless course.
(05 Mar 2000)
borderline hypertension By consensus, that blood pressure zone between highest acceptable "normal" blood pressure and hypertensive blood pressure. The Framingham Heart Study defines this as pressures between 140 and 160 mm Hg systolic and 90 and 95 mm Hg diastolic.
(05 Mar 2000)
pale hypertension Hypertension with pallor of the skin, a severe form with pronounced constriction of peripheral vessels.
(05 Mar 2000)
malignant hypertension A severe form of acute hypertension that results in the abrupt rise in the blood pressure (diastolic pressure often over 120 mmHg). If left untreated, malignant hypertension can cause damage to the blood vessels in the eye, kidneys, brain and heart. Complications include stroke, heart attack, blindness and renal failure.
Symptoms include headache, blurred vision, nausea, vomiting and lethargy. Neurologic symptoms are also a common finding. Malignant hypertension occurs more commonly in males, African Americans and those with a history for hypertension.
(27 Sep 1997)
renal hypertension Hypertension secondary to renal disease.
(05 Mar 2000)
renovascular hypertension Hypertension produced by renal arterial obstruction.
(05 Mar 2000)
Goldblatt hypertension Increased blood pressure following obstruction of blood flow to one kidney.
Synonym: Goldblatt phenomenon.
(05 Mar 2000)
portal hypertension Any increase in the portal vein (in the liver) pressure due to anatomic or functional obstruction (for example alcoholic cirrhosis) to blood flow in the portal venous system. Indicators of portal hypertension are: oesophageal varices, haemorrhoids, enlarged veins on the anterior abdominal wall (caput Medusae) and ascites (fluid within the abdominal cavity).
(27 Sep 1997)
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 1 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated
    ¼Ó·ÂÀÌ ºÙÀº;°¡¼ÓµÈ
  • hypertension
    °íÇ÷¾Ð; °úµµ ±äÀå
  • hypertension
    °íÇ÷¾Ð
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á